Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
Yanki Yarman, MD and Ph.D. Student at Sidney Kimmel Medical College, shared a post on LinkedIn about a recent article by Marvin T. Nieman, published in ASH, adding:
“I’m truly touched and honored by this Blood commentary penned by Dr. Marvin Nieman on my PhD project.
I’m especially grateful for his description of our study and its comprehensive methods ‘as a model for future studies aiming to connect genetic variants with molecular mechanisms and clinical outcomes.’
As a physician-scientist in training, I care deeply about genetically screening patients and understanding the molecular pathways underlying their diseases.
I hope to practice personalized medicine in the near future.
Here’s the Blood commentary on the GRK5 variant that we linked to increased thrombotic risk.”
Title: GRK5 polymorphism turns up the volume on PAR1
Auhtors: Marvin Nieman
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!